Drug trial led by Cincinnati researchers gains national media attention

Dr. Evan Stein, director of the Metabolic and Atherosclerosis Research Center in Cincinnati, is leading clinical trials for a new drug candidate (REGN727) that may do a better job of lowering cholesterol than statins, and with fewer side effects. The New York Times and ABC News took notice last month.

Dr. Evan Stein

Study results were published in a recent issue of The New England Journal of Medicine.

“About 5 to 10 percent of people can’t tolerate statins at all, and more can’t tolerate higher doses,” said Dr. Evan A. Stein, director of the Metabolic and Atherosclerosis Research Center in Cincinnati and lead author of the drug trials. “It’s still early in development, but for them this is potentially a most promising alternative.”

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

BioKansas to celebrate 10 year anniversary and tenure of retiring President and CEO Angela Kreps | BioKansas, October 24, 2014

Patients & Consumers Pharma receives $500k from Dayton’s Accelerant Fund | Dayton Business Journal, October 24, 2014

Cleveland Clinic Medical Innovation Summit opens Sunday with a focus on personalized cancer treatments | Cleveland.com, October 23, 2014

Philips Healthcare resumes medical imaging manufacturing in Highland Heights | Crains Cleveland, October 23, 2014

HealthSpot wins telemedicine fans in Cleveland, but Nationwide Children’s presses pause | Columbus Business First, October 23, 2014

Advanced BioSensors-Ohio and Real Time Imaging Technologies finalists in PtotoTech pitch contest | Fresh Water Cleveland, October 22, 2014

NuVasive Manufacturing in Fairborn adding 35 positions, double production during the next three to five years | Dayton Business Journal, October 22, 2014

STERIS relocating global specialty services HQ to Birmingham, AL, hiring 200 | Birmingham Business Journal, October 22, 2014

Porter Wright getting new managing partner, Bob Tannous will take over for Robert Trafford | Columbus Business First, October 22, 2014

Contract sterilization company Sterigenics may be up for sale | Reuters, October 22, 2014

Cardinal Health donates one million medical products to help fight Ebola in West Africa | The Columbus Dispatch, October 21, 2014

Procter & Gamble hiring soon for distribution center in Union’s Global Logistics Airpark | WDTN2 News, October 21, 2014

Central Ohio career technical education partnerships are shaping tomorrow’s workforce today | Columbus CEO, October 21, 2014

NanoLogix developing rapid test for Ebola virus (video) | WYTV33 Youngstown, October 21, 2014

Analytic, a partnership of Anatrace and Microlytic: enabling membrane protein research | PR Web, October 21, 2014

Quasar Energy Group uses organic waste to produce renewable energy | Todays Energy Solutions, October 21, 2014

Frank Samuel, President of VentureOhio and former BioOhio President dies in auto accident | Geauga County Maple Leaf, October 21, 2014

X-spine announces launch of Axograft Biologics Portfolio | X-Spine, October 20, 2014

Milo Biotechnology’s follistatin gene therapy increases function in Becker Muscular Dystrophy patients | PR Newswire, October 20, 2014

Skilled Care Pharmacy and Assurex Health announce partnership to provide GeneSight genetic test | Assurex Health, October 20, 2014